Jacob G. Scott, MD, DPhil, discusses the incorporation of genomic-adjusted radiation dose–based radiotherapy dosing in oncology.
Jacob G. Scott, MD, DPhil
Advertisement
Articles by Jacob G. Scott, MD, DPhil
Jacob G. Scott, MD, DPhil, discusses the rationale to evaluate genomic-adjusted radiation dose–based radiotherapy dosing in oncology.
Advertisement
Latest Updated Articles
Dr. Scott on the Incorporation of GARD-Based Radiotherapy Dosing in OncologyPublished: August 30th 2021 | Updated:
Dr. Scott on the Rationale to Evaluate GARD-Based Radiotherapy Dosing in OncologyPublished: August 18th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5